STOCK TITAN
  1. Home
  2. Sec-filings
  3. KRYS
  4. [Form 4] Krystal Biotech, Inc. Insider Trading Activity

[Form 4] Krystal Biotech, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock KRYS logo
Krystal Biotech

NASDAQ:KRYS

KRYS Rankings

#1766 Ranked by Market Cap
N/A Ranked by Dividends

KRYS Latest News

Jul 9, 2025
Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis
Jun 24, 2025
Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis Bullosa
Jun 3, 2025
Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference
May 7, 2025
Krystal Biotech to Present at BofA Securities 2025 Health Care Conference
May 6, 2025
Krystal Biotech Announces First Quarter 2025 Financial and Operating Results

KRYS Latest SEC Filings

Jul 16, 2025
[Form 4] Krystal Biotech, Inc. Insider Trading Activity
Jul 11, 2025
[Form 4] Krystal Biotech, Inc. Insider Trading Activity
Jul 11, 2025
[Form 4] Krystal Biotech, Inc. Insider Trading Activity
Jul 9, 2025
[144] Krystal Biotech, Inc. SEC Filing
Jul 9, 2025
[144] Krystal Biotech, Inc. SEC Filing

KRYS Stock Data

4.30B
24.75M
12.24%
105.95%
9.59%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
PITTSBURGH